119 Results

People

  1. Hudis
    Hudis
  2. Lewis
    Lewis
  3. Modi
    Modi
  4. Baselga
    Baselga
  5. Chandarlapaty
    Chandarlapaty
  6. Ross
    Ross
  7. Ilson
    Ilson
  8. Janjigian
    Janjigian
  9. Jhaveri
    Jhaveri
  10. Patil
    Patil

Groups

  1. Department of Medicine (74)
  2. Solid Tumor Oncology Division (71)
  3. Breast Medicine Service (42)
  4. Survivorship Research (31)
  5. GSK Faculty (29)
  6. Department of Pathology and Laboratory Medicine (25)
  7. Radiology, Department of (21)
  8. Sloan Kettering Institute Postdocs (21)
  9. Gastrointestinal Oncology Service (19)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  1. "her2"
Formats
  1. Journal Article (103)
  2. Review (13)
  3. Meeting Abstract (2)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (74)
  2. Solid Tumor Oncology Division (71)
  3. Breast Medicine Service (42)
  4. Survivorship Research (31)
  5. GSK Faculty (29)
  6. Department of Pathology and Laboratory Medicine (25)

More Groups

People
  1. Clifford Hudis (18)
  2. Jose Baselga (11)
  3. Jason Lewis (10)
  4. Shanu Modi (10)
  5. Sarat Chandarlapaty (9)
  6. Dara Ross (8)

More People

Years
  1. 2025 (1)
  2. 2024 (15)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (2)
  6. 2020 (7)

More Years

Publications
  1. Breast Cancer Research and Treatment (9)
  2. Annals of Oncology (8)
  3. Journal of Nuclear Medicine (5)
  4. Clinical Breast Cancer (4)
  5. Journal of Thoracic Oncology (4)
  6. Oncogene (4)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. Springer (18)
  3. Oxford University Press (9)
  4. Nature Publishing Group (7)
  5. Informa Healthcare (6)
  6. Lippincott Williams & Wilkins (6)

More Publishers

Results (119)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antitumor activity and safety of trastuzumab deruxtecan in patients with HER2-low-expressing advanced breast cancer: Results from a phase Ib study
    Journal Article

    Modi, S.; Park, H.; Murthy, R. K.; Iwata, H.; Tamura, K.; Tsurutani, J.; Moreno-Aspitia, A.; Doi, T.; Sagara, Y.; Redfern, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Incidence and management of diarrhea with adjuvant pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive breast cancer
    Journal Article

    Bines, J.; Procter, M.; Restuccia, E.; Viale, G.; Zardavas, D.; Suter, T.; Arahmani, A.; Van Dooren, V.; Baselga, J.; Clark, E.; more...
    Clinical Breast Cancer (2020)

    Fulltext@MSK | Save
  • HER2-targeted PET imaging and therapy of hyaluronan-masked HER2-overexpressing breast cancer
    Journal Article

    Pereira, P. M. R.; Ragupathi, A.; Shmuel, S.; Mandleywala, K.; Viola, N. T.; Lewis, J. S.
    Molecular Pharmaceutics (2020)

    Fulltext@MSK | Save
  • Antibody-drug conjugates in urothelial carcinomas
    Review

    Sarfaty, M.; Rosenberg, J. E.
    Current Oncology Reports (2020)

    Fulltext@MSK | Save
  • The influence of glycans-specific bioconjugation on the FcγRI binding and in vivo performance of (89)Zr-DFO-pertuzumab
    Journal Article

    Vivier, D.; Fung, K.; Rodriguez, C.; Adumeau, P.; Ulaner, G. A.; Lewis, J. S.; Sharma, S. K.; Zeglis, B. M.
    Theranostics (2020)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: Results from the NCI-MATCH trial (EAY131) subprotocol Q
    Journal Article

    Jhaveri, K. L.; Wang, X. V.; Makker, V.; Luoh, S. W.; Mitchell, E. P.; Zwiebel, J. A.; Sharon, E.; Gray, R. J.; Li, S.; McShane, L. M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Precision medicine for metastatic colorectal cancer: An evolving era
    Review

    Guler, I.; Askan, G.; Klostergaard, J.; Sahin, I. H.
    Expert Review of Gastroenterology and Hepatology (2019)

    Fulltext@MSK | Save
  • Temporal modulation of HER2 membrane availability increases pertuzumab uptake and pretargeted molecular imaging of gastric tumors
    Journal Article

    Pereira, P. M. R.; Mandleywala, K.; Ragupathi, A.; Carter, L. M.; Goos, J. A. C. M.; Janjigian, Y. Y.; Lewis, J. S.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: The SAFE-HEaRt study
    Journal Article

    Lynce, F.; Barac, A.; Geng, X.; Dang, C.; Yu, A. F.; Smith, K. L.; Gallagher, C.; Pohlmann, P. R.; Nunes, R.; Herbolsheimer, P.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: Results from a prospective multi-institutional study (the APT trial)
    Journal Article

    Bellon, J. R.; Guo, H.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save